Indar Jhamb, MD
Allergy & Immunology · Bowling Green, KYNPI 1790876407
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 306 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for allergy & immunology clinicians in KY, where the typical reported total is $7,092.
Across 306 payments — averaging $19.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$1K
- AstraZeneca$898
- GSK$837
- Pfizer$538
- Kaleo, Inc.$328
- Regeneron Healthcare Solutions, Inc.$320
- plus $2K from 22 others
What the payments were for
- Food & beverage$5,92798%
- Education$942%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 65 | $1,411 |
| AstraZeneca | 37 | $898 |
| GSK | 60 | $837 |
| Pfizer | 36 | $538 |
| Kaleo, Inc. | 17 | $328 |
| Regeneron Healthcare Solutions, Inc. | 16 | $320 |
| Mylan Specialty L.p. | 13 | $261 |
| Teva Pharmaceuticals USA, Inc. | 11 | $220 |
| Galderma Laboratories, L.p. | 2 | $142 |
| Amgen | 5 | $122 |
| Alk-abello, Inc | 7 | $118 |
| Lilly USA, LLC | 1 | $115 |
| Pharming Healthcare, Inc. | 5 | $100 |
| Optinose US, Inc. | 5 | $75 |
| Novartis | 3 | $59 |
| Boehringer Ingelheim | 3 | $58 |
| Blueprint Medicines Corporation | 3 | $54 |
| Octapharma USA, Inc. | 1 | $53 |
| Hikma Pharmaceuticals USA | 3 | $52 |
| Sunovion Pharmaceuticals Inc. | 2 | $37 |
| Circassia Inc. | 2 | $35 |
| Dermavant Sciences, Inc. | 1 | $34 |
| Genentech USA, Inc. | 2 | $33 |
| Merck | 2 | $28 |
| Aimmune Therapeutics, Inc. | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Incyte Corporation | 1 | $21 |
| USWM, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,020 in reported general payments places this provider in the 45th percentile of 66 allergy & immunology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TezspireTezepelumab-Ekko | 17 | $70,521 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 81 | $53,774 |
| Dupixent PenDupilumab | 14 | $52,354 |
| NucalaMepolizumab | 12 | $43,558 |
| Spiriva RespimatTiotropium Bromide | 25 | $18,077 |
| Breo ElliptaFluticasone/Vilanterol | 20 | $14,853 |
| Advair HfaFluticasone Propion/Salmeterol | 21 | $10,333 |
| Epinephrine | 33 | $8,109 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 19 | $7,276 |
| Arnuity ElliptaFluticasone Furoate | 13 | $6,860 |
| RyaltrisOlopatadine Hcl/Mometasone | 21 | $6,019 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 33 | $4,161 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 17 | $3,764 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 88 | $3,174 |
| BreynaBudesonide/Formoterol Fumarate | 18 | $2,982 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Nucala, Breo Ellipta, Arnuity Ellipta | $837 | $119,045126 claims |
| AstraZenecaTezspire | $898 | $70,52117 claims |
| Boehringer IngelheimSpiriva Respimat | $58 | $18,07725 claims |
| Hikma Pharmaceuticals USAEpinephrine, Ryaltris | $52 | $14,12854 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 66 allergy & immunology providers in Kentucky.
Other allergy & immunology in Bowling Green
- Thomas SternbergBowling Green$17K
- James ParkersonBowling Green$8K
- Kourtney GardnerBowling Green$7K
- Patricia MercerBowling Green$3K
- Lee CloreOwensboro$841K
- James SublettLouisville$588K
- Hans OttoFlorence$381K
- Stephen PollardLouisville$301K
- Douglas LotzLouisville$199K
- James SublettLouisville$194K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.